STOCK TITAN

Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will present a company overview and financial updates at three virtual investor conferences in May 2021. The events include the BofA Securities Health Care Conference on May 11 at 1:15 p.m. ET, the RBC Capital Markets Global Healthcare Conference on May 18 at 10:40 a.m. ET, and the UBS Global Healthcare Virtual Conference on May 24 at 11:00 a.m. ET. Interested parties can access the live webcasts on Jazz Pharmaceuticals' website, with replays available for at least a week.

Jazz focuses on developing medicines for serious diseases in neuroscience and oncology.

Positive
  • None.
Negative
  • None.

DUBLIN, May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the following virtual investor conferences:

  • BofA Securities 2021 Health Care Conference on Tuesday, May 11, 2021 at 1:15 p.m. ET / 6:15 p.m. IST
  • RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 10:40 a.m. ET / 3:40 p.m. IST
  • UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 11:00 a.m. ET / 4:00 p.m. IST

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be archived on the website for at least one week.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing life-changing medicines for people with serious diseases — often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is in neuroscience, including sleep medicine and movement disorders, and in oncology, including hematologic malignancies and solid tumors. We actively explore new options for patients including novel compounds, small molecules, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

Jazz Pharmaceuticals Contacts:




Investors: 
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
investorinfo@jazzpharma.com
Ireland +353 1 63 43211

Media:
Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations
CorporateAffairsMediaInfo@jazzpharma.com  
Ireland +353 1 697 2141
U.S. +1 215 867 4910

 

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-three-investor-conferences-in-may-2021-301283726.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals present at the BofA Securities 2021 Health Care Conference?

Jazz Pharmaceuticals will present on May 11, 2021, at 1:15 p.m. ET.

What are the dates for Jazz Pharmaceuticals' upcoming investor conferences?

Jazz will participate in three conferences on May 11, May 18, and May 24, 2021.

How can I access the live webcasts for Jazz Pharmaceuticals' investor conferences?

The live audio webcasts can be accessed via the Investors section of the Jazz Pharmaceuticals website.

What is the focus of Jazz Pharmaceuticals in their product development?

Jazz Pharmaceuticals focuses on developing medicines in neuroscience, including sleep medicine and oncology, addressing serious diseases.

Jazz Pharmaceuticals, Inc.

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Stock Data

7.65B
58.63M
2.94%
98.78%
5.94%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
DUBLIN